Related Experiment Video
Updated: Dec 30, 2025

11:34
Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
7.0K
Single-Stranded DNA Aptamers Against TNF and Their Potential Applications
Shao Tao1,2,3, Pingfang Song1,2, Xiaowei Zhang1,2
1Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, OR, USA.
Methods in Molecular Biology (Clifton, N.J.)
|January 16, 2020
Summary
DNA aptamers were developed to block Tumor Necrosis Factor (TNF), a key factor in autoimmune diseases. These aptamers show potential as cost-effective alternatives to current biologic drugs and for in vivo TNF detection.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Aptamers are short nucleic acid sequences with high affinity for specific targets.
- Tumor Necrosis Factor (TNF) is a critical inflammatory cytokine in autoimmune diseases.
- Current TNF inhibitors are effective but costly and not universally responsive.
Purpose of the Study:
- To select and characterize DNA aptamers targeting TNF.
- To evaluate the potential of these aptamers as TNF inhibitors.
- To explore their use as diagnostic probes for TNF.
Main Methods:
- Systematic Evolution of Ligands by Exponential Enrichment (SELEX) was used to identify DNA aptamers against TNF.
- The selected aptamers' binding affinity and specificity for TNF were assessed.
- The bioactivity of aptamers in blocking TNF-mediated cytotoxicity in vitro was evaluated.
Main Results:
- Novel single-stranded DNA aptamers that bind specifically to TNF were successfully selected.
- These aptamers demonstrated significant inhibition of TNF-mediated cytotoxicity in cellular assays.
- The selected aptamers represent a promising new class of TNF-targeting molecules.
Conclusions:
- DNA aptamers offer a viable alternative to current biological TNF inhibitors.
- Aptamers can be engineered for therapeutic applications in autoimmune diseases.
- Selected aptamers hold potential for developing in vivo probes for TNF detection.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
396
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
396
Single-Strand DNA Binding Proteins
16.4K
For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...
16.4K

